Abstract:
General Background: Biofilm-associated infections represent a major clinical challenge due to their persistence and resistance to antibiotics. Specific Background: Staphylococcus aureus is a common pathogen implicated in chronic and hospital-acquired infections, particularly due to its biofilm-forming capability. Knowledge Gap: Despite global reports on S. aureus resistance, limited data exist regarding its biofilm formation and antibiotic susceptibility in clinical isolates from Mashhad Hospital. Aims: This study aimed to investigate the prevalence, biofilm formation, and antibiotic resistance profile of S. aureus isolated from hospitalized patients. Results: A total of 150 clinical samples (blood, urine, wounds, and secretions) were collected from 95 male and 55 female patients, yielding 70 S. aureus isolates. All isolates were biofilm-positive. Antibiotic susceptibility testing revealed 100% resistance to ampicillin, 80.3% to azithromycin, and 70.7% to cefoxitin, while all isolates remained sensitive to vancomycin and clarithromycin. Statistical analysis showed significant associations (p < 0.05) between patient sex and both biofilm formation and antibiotic resistance patterns. Novelty: This study provides updated, localized resistance data and highlights the universal biofilm-forming potential of S. aureus in this region. Implications: The findings underscore the need for enhanced infection control strategies and the prudent use of antibiotics to mitigate biofilm-related resistance in hospital settings.
Highlights:
- S. aureus causes resistant, biofilm-related hospital infections.
- 70 isolates: all biofilm-positive, high resistance to common antibiotics.
- Requires improved antibiotic stewardship and infection control measures.
Keywords: S. aureus, Antibiotic Resistance, Biofilm, Clinical samples
References
T. J. Foster, “Surface Proteins ofStaphylococcus aureus,” Microbiology Spectrum, vol. 7, no. 4, Jul. 2019, doi: 10.1128/microbiolspec.gpp3-0046-2018.
K. Tam and V. J. Torres, “Staphylococcus aureusSecreted Toxins and Extracellular Enzymes,” Microbiology Spectrum, vol. 7, no. 2, Mar. 2019, doi: 10.1128/microbiolspec.gpp3-0039-2018.
K. Tam and V. J. Torres, “Staphylococcus aureusSecreted Toxins and Extracellular Enzymes,” Microbiology Spectrum, vol. 7, no. 2, Mar. 2019, doi: 10.1128/microbiolspec.gpp3-0039-2018.
C. Ezeamagu et al, “Detection of methicillin resistant and toxin-associated genes in Staphylococcus aureus”, Beni-Suef University Journal of Basic and Applied Sciences, vol. 7, no. 1, pp 92-7, Mar 2018.
D. M. Mrochen, L. M. F. De Oliveira, D. Raafat, and S. Holtfreter, “Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models,” International Journal of Molecular Sciences, vol. 21, no. 19, p. 7061, Sep. 2020, doi: 10.3390/ijms21197061.
M. Egorov, M. M. Ulyashova, M. Y. Rubtsova, “Bacterial enzymes and antibiotic resistance,” PubMed, Dec. 01, 2018. https://pubmed.ncbi.nlm.nih.gov/30713760/
K. G. Kaiser et al., “Nanosilver: An Old Antibacterial Agent with Great Promise in the Fight against Antibiotic Resistance,” Antibiotics, vol. 12, no. 8, p. 1264, Jul. 2023, doi: 10.3390/antibiotics12081264.
O. F. Martínez, M. H. Cardoso, S. M. Ribeiro, and O. L. Franco, “Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, Quorum-Sensing interference and biofilm inhibition,” Frontiers in Cellular and Infection Microbiology, vol. 9, Apr. 2019, doi: 10.3389/fcimb.2019.00074.
O. F. Martínez, H. M. Duque, and O. L. Franco, “Peptidomimetics as potential Anti-Virulence drugs against resistant bacterial pathogens,” Frontiers in Microbiology, vol. 13, Apr. 2022, doi: 10.3389/fmicb.2022.831037.
Q. S. Hmood, R. A. Abd, R. Y. Muttair, M. J. Mohammed, and H. F. Okab, “Premarital screening uncovers alarming health risks in Iraq,” Academia Open, vol. 9, no. 2, Sep. 2024, doi: 10.21070/acopen.9.2024.10014.
X. Liu, H. Yao, X. Zhao, and C. Ge, “Biofilm formation and control of foodborne pathogenic bacteria,” Molecules, vol. 28, no. 6, p. 2432, Mar. 2023, doi: 10.3390/molecules28062432.
O. Haddad, A. Merghni, A. Elargoubi, H. Rhim, Y. Kadri, and M. Mastouri, “Comparative study of virulence factors among methicillin resistant Staphylococcus aureus clinical isolates,” BMC Infectious Diseases, vol. 18, no. 1, Nov. 2018, doi: 10.1186/s12879-018-3457-2.
H. Ghaderi, E. Shiri Malekabad, M. Vahidi, A. R. Dadashi, “Evaluation of genotypic and phenotypic biofilm formation by Staphylococcus aureus isolated from clinical samples and their association with antimicrobial resistance”, Iranian Journal of Medical Microbiology, VO. 14, NO. 5, PP. 441-59, Sep 2020.
Z. T. Baghbaderani, A. Shakerian, and E. Rahimi, “
Phenotypic and Genotypic Assessment of Antibiotic Resistance of Staphylococcus aureus Bacteria Isolated from Retail Meat
,” Infection and Drug Resistance, vol. Volume 13, pp. 1339–1349, May 2020, doi: 10.2147/idr.s241189.T. O. Y. Bayraktar, “Investigation of antibiotic resistance among Staphylococcus aureus strains of human and bovine origin,” Ankara Üniversitesi Veteriner Fakültesi Dergisi, vol. 59, no. 3, pp. 191–196, Jan. 2012, doi: 10.1501/vetfak_0000002524.
S. Handwerger et al., “Nosocomial Outbreak Due to Enterococcus faecium Highly Resistant to Vancomycin, Penicillin, and Gentamicin,” Clinical Infectious Diseases, vol. 16, no. 6, pp. 750–755, Jun. 1993, doi: 10.1093/clind/16.6.750.